Of note, among the genes repressed by AMPK was KLK2, a prostate cancer marker and a well-established AR target gene that belongs to the same gene family (kallikrein-related peptidases) as prostate specific antigen (PSA / KLK3). This evidence concerns the gene PRKAA2 and prostate carcinoma.